NeoGenomics, Inc. (NEO)
7.995
+0.24
(+3.16%)
USD |
NASDAQ |
Apr 02, 16:00
8.00
0.00 (0.00%)
Pre-Market: 20:00
NeoGenomics Total Liabilities (Quarterly) : 523.27M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 156.03M |
| Amphastar Pharmaceuticals, Inc. | 888.89M |
| Krystal Biotech, Inc. | 114.23M |
| Alignment Healthcare, Inc. | 886.51M |
| Monte Rosa Therapeutics, Inc. | 215.60M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.360B |
| Shareholders Equity (Quarterly) | 836.56M |
| Debt to Equity Ratio | 0.4895 |
| Current Ratio | 4.260 |
| Net Debt Paydown Yield | 2.59% |